CLDF Title
Contact Us | Bookmark
HBV HCC HCV HE NASH PBC
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
NASH-TAG 2016       IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
Cancer incidence differs between African- and U.S.-born blacks
04-17-2017
Younger donor age tied to better survival after living-donor liver transplant
04-14-2017
Moderate alcohol use could be safe with methotrexate for RA
04-12-2017
NAFLD recurs in most patients who undergo transplant for NASH
04-03-2017
Overweight, obese young men at increased risk of liver disease
03-31-2017
View Complete News Library
 
 
April 29 - May 3
AMERICAN TRANSPLANT CONGRESS
Chicago, IL
May 6-9
DDW 2017
Chicago, IL
May 10-13
50th ANNUAL MEETING- THE EUROPEAN SOCIETY FOR PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION (ESPGHAN)
Prague, Czech Republic
May 24-27
ANNUAL INTERNATIONAL CONGRESS OF THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY (ILTS)
Prague, Czech Republic
September 15-17
11th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Seoul, South Korea
View all Congresses
 
 
 
 
 
 
  Line  
  Featured Abstracts          
 
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
 
Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
 
Genotype specific peripheral lipid profile changes with hepatitis C therapy
 
Hepatitis C Virus: A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy
 
Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study
 
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras
 
 
Treatment of chronic hepatitis B infection-2017
 
Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
 
Occupational Health Update: Focus on Preventing the Acquisition of Infections with Pre-exposure Prophylaxis and Postexposure Prophylaxis
 
Infrequent clinical assessment of chronic hepatitis B patients in United States general healthcare settings
 
A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis
 
Optimal treatment of hepatic encephalopathy
 
 
Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis
 
Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study
 
Palliative interventions for hepatocellular carcinoma patients: analysis of the National Cancer Database
 
Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions
 
Treatment of Non-Alcoholic Fatty Liver Disease
 
Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy
 
 
          View All Abstracts  
  Line  
                         
 
HBV
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
 
HE
Webcasts
Slide Library
Abstract Library
 
NASH
Webcasts
Slide Library
Abstract Library
 
 
PBC
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Hepatology
Substance Use Disorder
         
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2017 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.